Business valuation experts have lost credibility because they cannot support the company-specific risk premium (CSRP) in the capital asset pricing model (CAPM). Although most valuation and finance professionals agree that risks beyond market risk as measured by beta (β) increase a private company's cost of common equity (Ke), they have been unable to agree on the effect.
Copyright American Society of Appraisers
The information contained in this product is based on content obtained by ASA from sources considered to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. BVR and ASA accept no liability for the use of such information which is provided "AS IS" and with no warranties, express or implied.